
L’Oréal: Sales, Armani Stake, and Kering Deal Impact
L'Oréal reports sales growth amid market challenges. Considers Armani stake post-Giorgio Armani's will. Kering deal, including Creed, expands fragrance presence. Focus on China & US markets.

L'Oréal reports sales growth amid market challenges. Considers Armani stake post-Giorgio Armani's will. Kering deal, including Creed, expands fragrance presence. Focus on China & US markets.

L'Oréal and Kering partner in a major beauty licensing deal. L'Oréal gains rights to brands like Bottega Veneta and Balenciaga, while Kering focuses on royalties and debt reduction, shifting its beauty strategy.

Giorgio Armani's will reveals potential partnerships with LVMH, L'Oréal, or EssilorLuxottica for his fashion house. An IPO is also possible. The will outlines selling stake.

L'Oréal's Q2 2025 sales rose 2.4%, boosted by China. Haircare excelled, but skincare disappointed. The group navigates economic stress and invests in dermatological brands for future growth. Focus: Innovation.